CT-322 in Treating Patients With Advanced Solid Tumors and Non-Hodgkin's Lymphoma
Clinical trial NCT00374179 · COMPLETED
Trial details
- NCT number
- NCT00374179
- Sponsor
- Adnexus, A Bristol-Myers Squibb R&D Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-08-01
- Primary completion
- 2008-11-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.